The death rate of COVID-19 has changed dramatically since the pandemic began. Early in 2020, the global case fatality rate was several percent or higher in many countries. By 2023 and into 2024, that figure had dropped well below 1% in most of the world, thanks to widespread immunity from vaccination and prior infection, improved treatments, and the shift toward less lethal virus variants.
Case Fatality Rates Around the World
The case fatality rate (CFR), meaning the percentage of confirmed cases that result in death, has always varied widely by region. A global retrospective analysis covering 2019 through 2023 found that Africa had the highest cumulative CFR at about 2%, while Oceania (Australia, New Zealand, and Pacific Island nations) had the lowest at roughly 0.2%. These numbers reflect not just biology but also differences in testing capacity, healthcare access, population age, and how thoroughly cases were counted. Countries that tested less broadly appeared to have higher fatality rates because mild cases went unrecorded.
Every region saw its CFR decline over time. Africa’s mortality peaked in the first half of 2021, then fell steadily. Oceania spiked briefly in late 2020 before settling at consistently low levels. By late 2022 and 2023, even regions with historically higher fatality rates were trending downward.
Confirmed Deaths vs. Actual Toll
Official death counts significantly understate how many people actually died. Between January 2020 and December 2021, governments worldwide reported 5.94 million COVID-19 deaths. But a systematic analysis published in The Lancet estimated that 18.2 million excess deaths occurred during that same period, roughly three times the official figure. Excess mortality captures deaths that were never tested or attributed to COVID-19, plus deaths caused indirectly by overwhelmed healthcare systems. In many low- and middle-income countries, the gap between reported and actual deaths was especially large.
How Vaccination Changed the Numbers
Vaccines produced the single largest reduction in COVID-19 mortality. CDC data from 24 U.S. jurisdictions between late 2021 and December 2022 showed that during the Delta wave, unvaccinated people died at roughly 50 times the rate of those who had recently received a booster. That gap narrowed as the virus evolved, but it remained substantial. During the Omicron BA.4/BA.5 wave, unvaccinated individuals still died at 14 times the rate of people who had received an updated bivalent booster, translating to about 93% vaccine effectiveness against death.
Protection did wane over time. Among those who received a monovalent booster, the mortality rate ratio comparing unvaccinated to boosted individuals dropped from about 7.2 within the first few months to 2.5 after a year. Updated boosters restored much of that protection. For older adults, the effect was even more pronounced: unvaccinated people aged 65 to 79 died at nearly 24 times the rate of those with a bivalent booster.
Who Faces the Highest Risk
Age has been the strongest single predictor of COVID-19 death from the beginning and remains so. Beyond age, several chronic conditions substantially raise the risk of severe outcomes. Data from 2022 to 2023 published in the American Journal of Preventive Medicine found that adults with chronic kidney disease were hospitalized at 4.5 times the rate of those without it. Diabetes doubled the hospitalization rate, as did a history of stroke, severe obesity, and coronary artery disease. Chronic obstructive pulmonary disease nearly doubled it, and smoking and asthma each raised the rate by about 50%.
One notable finding: non-severe obesity on its own was not associated with increased risk. The elevated danger applied specifically to severe obesity, generally defined as a BMI of 40 or higher.
Why the Death Rate Keeps Falling
Several factors have converged to push mortality steadily lower. The Omicron lineage, which became dominant in late 2021, causes less severe lung disease than earlier variants like Delta. Nearly everyone now carries some immune memory from vaccination, prior infection, or both. And hospitals got better at managing critically ill patients. A study of more than 7.8 million hospitalizations across 715 U.S. hospitals found that in-hospital mortality declined significantly after late 2021, returning to pre-pandemic trends. By early 2024, the standardized mortality ratio had fallen to 0.80, meaning hospitals were actually performing 20% better than their pre-COVID baseline, likely reflecting improvements in care practices adopted during the crisis.
Newer Omicron subvariants continue to circulate and evolve. The CDC flagged a subvariant called BA.3.2 in early 2026 as one worth monitoring, though early cases, including hospitalized older adults with other health conditions, all survived. So far, no recent variant has reversed the overall downward trend in severity.
What the Numbers Mean Now
For a healthy, vaccinated adult in a country with modern healthcare, the risk of dying from a COVID-19 infection in 2024 or 2025 is very low, likely a small fraction of 1%. For an unvaccinated older adult with chronic kidney disease or diabetes, the risk is meaningfully higher, though still far below what it was in 2020. The virus has not disappeared, and it still kills tens of thousands of people globally each year, disproportionately those who are elderly, immunocompromised, or living without access to vaccines and treatment. Staying current on boosters remains the most effective way to keep individual risk at its lowest.